Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

338
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
338
Causality in Epidemiology01:21

Causality in Epidemiology

2.1K
Causality or causation is a fundamental concept in epidemiology, vital for understanding the relationships between various factors and health outcomes. Despite its importance, there's no single, universally accepted definition of causality within the discipline. Drawing from a systematic review, causality in epidemiology encompasses several definitions, including production, necessary and sufficient, sufficient-component, counterfactual, and probabilistic models. Each has its strengths and...
2.1K
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

748
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
748
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

564
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
564
Censoring Survival Data01:09

Censoring Survival Data

664
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
664
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

717
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
717

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multi-arm multi-stage platform trials for neurological disease: accelerating progress.

Lancet (London, England)·2026
Same author

Repurposed drug prioritization pipeline for a multi-arm platform trial in clinical Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Sample Size Calculation for the ROCI Design.

Statistics in medicine·2026
Same author

Breast cancer incidence and predictive parish-level social determinants of health in and around Kampala, Uganda.

Archives of public health = Archives belges de sante publique·2026
Same author

Patient and public involvement and engagement in clinical trials at scale: Analysis of the first 3250 responses on the POrtal for Patient and Public Engagement in Dementia (POPPED).

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Distinct Chiral Nanostructures of Graphene Quantum Dots Govern Divergent Passive and Active Enantioselective Transport across Biological Membranes.

bioRxiv : the preprint server for biology·2026
Same journal

Correction.

Journal of biopharmaceutical statistics·2026
Same journal

Leveraging external controls in clinical trials: estimands, estimation, assumptions.

Journal of biopharmaceutical statistics·2026
Same journal

Special issue of nonclinical statistics in regulatory applications guest editors' notes.

Journal of biopharmaceutical statistics·2026
Same journal

Comparison of flexible parametric modeling and nonparametric methods to estimate restricted mean survival time: A simulation study.

Journal of biopharmaceutical statistics·2026
Same journal

Simulated treatment comparisons with jackknife pseudo values for estimating population-adjusted marginal treatment effects.

Journal of biopharmaceutical statistics·2026
Same journal

Sample sizes for randomized controlled trials utilizing Bayesian response adaptive randomization for continuous outcomes.

Journal of biopharmaceutical statistics·2026
See all related articles

Related Experiment Video

Updated: Apr 11, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.5K

Bayesian analysis of the causal reference-based model for missing data in clinical trials.

Brendah Nansereko1, Marcel Wolbers2, James Carpenter3

  • 1Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK.

Journal of Biopharmaceutical Statistics
|April 10, 2026
PubMed
Summary
This summary is machine-generated.

This study introduces a Bayesian approach to handle missing data in clinical trials caused by intercurrent events (ICEs). The method explicitly accounts for uncertainty in estimating treatment effects after ICEs, improving statistical analysis.

Keywords:
Estimandsintercurrent eventsreference based imputationvariance

More Related Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

11.1K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.8K

Related Experiment Videos

Last Updated: Apr 11, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.5K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

11.1K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.8K

Area of Science:

  • Biostatistics
  • Clinical Trial Methodology
  • Causal Inference

Background:

  • Missing data in clinical trials, often due to intercurrent events (ICEs), complicates statistical analysis.
  • Reference-based imputation methods are common for handling ICEs but have limitations in variance estimation.
  • Existing methods like Rubin's rules can be biased, and repeated sampling estimators may decrease with increasing ICEs.

Purpose of the Study:

  • To propose a novel Bayesian reference-based causal model to address uncertainty in estimating treatment effects after ICEs.
  • To provide a method that explicitly reflects uncertainty about the maintained treatment effect post-ICE.
  • To estimate the treatment policy treatment effect in trials with limited post-ICE data.

Main Methods:

  • Developed a Bayesian framework building upon the causal model of White et al. (2019).
  • Introduced a prior distribution for the maintained effect parameter to quantify uncertainty.
  • Employed simulations and an anti-depressant trial for validation and comparison.

Main Results:

  • The proposed Bayesian approach offers inference that directly incorporates uncertainty regarding the maintained treatment effect.
  • Demonstrated the ability to estimate treatment policy effects even with minimal post-ICE data.
  • Simulations compared the frequentist properties of the new method against existing reference-based techniques.

Conclusions:

  • The Bayesian reference-based causal model provides a robust method for handling missing data due to ICEs in clinical trials.
  • This approach enhances the estimation of treatment effects by acknowledging and quantifying uncertainty.
  • Applicable to trials with limited post-ICE data, offering improved statistical rigor.